DJIA 17,949.72 -85.21 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

66.29 1.13 (1.73%)

REAL-TIME: Last trade at

Extended Hours: $66.45 $0.16 (0.24%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ISIS $66.29 1.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.00
Previous Close $65.16
Daily Range $65.40 - $67.22
52-Week Range $22.25 - $77.80
Market Cap $7.9B
P/E Ratio -197.45
Dividend (Yield) $0.00 (0.0%)
Volume 2,027,656
Average Daily Volume 2,602,947
Current FY EPS -$0.79

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

How to Invest Money in Biotech

If you want to invest money in biotech, you first need to understand what catalysts tend to determine biotech stock valuations, and what your three best pathways are to becoming a successful biotech investor.

CAR-T Therapy Stocks Hit Hard Following AACR Data

It's A Big Weekend For Biotech

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

Jim Cramer -- If You're Not in Biotech for the Long Haul, Hit the Road

Isis And Durect Foray Into NASH; Durect Is The Better Bet

Is Isis Pharmaceuticals (ISIS) Stock a Solid Choice Right Now? - Tale of the Tape

Is Isis Pharmaceuticals (ISIS) Stock a Solid Choice Right Now? - Tale of the Tape

iShares Russell 2000 Growth ETF Experiences Big Outflow

ISIS Pharmaceuticals (ISIS) Strong In Pre-Market Trading

See More ISIS News...

ISIS's Top Competitors

ISIS $66.29 (1.73%)
Current stock: ISIS
AMGN $168.46 (1.50%)
Current stock: AMGN
GILD $105.20 (4.52%)
Current stock: GILD
BIIB $422.11 (-0.19%)
Current stock: BIIB